SiLi-D1
N/A
Report date: 2022/08/23 20:00:44
Base Information
Drug NameSiLi-D1
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesOncology Sciences CorpAmc Cancer Research Center
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A